Gestonorone caproate

Gestonorone caproate

Systematic (IUPAC) name
3,20-Dioxo-19-norpregn-4-en-17-yl hexanoate
Identifiers
CAS Number	1253-28-7
ATC code	G03DA01 (WHO) L02AB03 (WHO)
PubChem	CID 443881
ChemSpider	391969
Synonyms	Gestonorone hexanoate, gestronol hexanoate, gestronol caproate, norhydroxyprogesterone caproate
Chemical data
Formula	C26H38O4
Molar mass	414.57752 g/mol
SMILES CCCCCC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C(=O)C
InChI InChI=1S/C26H38O4/c1-4-5-6-7-24(29)30-26(17(2)27)15-13-23-22-10-8-18-16-19(28)9-11-20(18)21(22)12-14-25(23,26)3/h16,20-23H,4-15H2,1-3H3/t20-,21+,22+,23-,25-,26-/m0/s1 Key:XURCMZMFZXXQDJ-UKNJCJGYSA-N

Gestonorone caproate (INN, USAN, JAN) (brand names Depostat, Primostat), also known as gestronol hexanoate (BANM), as well as 17α-hydroxy-19-norprogesterone caproate, is a synthetic, steroidal progestin.^{[1][2][3][4][5]} As a depot administered via intramuscular injection, it is used in the treatment of benign prostatic hypertrophy (BPH) and endometrial cancer.^[6]

See also

• Hydroxyprogesterone caproate

References

1. J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 595–. ISBN 978-1-4757-2085-3.
2. Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. p. 488. ISBN 978-3-88763-075-1.
3. I.K. Morton; Judith M. Hall (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 132–. ISBN 978-94-011-4439-1.
4. Muller (19 June 1998). European Drug Index: European Drug Registrations, Fourth Edition. CRC Press. pp. 338–. ISBN 978-3-7692-2114-5.
5. William Andrew Publishing (22 October 2013). Pharmaceutical Manufacturing Encyclopedia, 3rd Edition. Elsevier. pp. 1761–1762. ISBN 978-0-8155-1856-3.
6. David E. Thurston (22 November 2006). Chemistry and Pharmacology of Anticancer Drugs. CRC Press. pp. 154–155. ISBN 978-1-4200-0890-6.